ByTrending Posts
Can VUMC’s New AI Technologies Reshape Cancer Diagnostics…
Key Highlights AI-Powered MSI-SEER Revolutionizes Tumor ProfilingVanderbilt University Medical Center (VUMC), in collaboration with Mayo Clinic and leading…
How Carterra, Pfizer, and GSK Are Scaling AI…
Key Highlights AI at the Core of the Next Drug Discovery WaveCarterra Inc., a front-runner in high-throughput biology,…
How Is Caltech’s AI Smart Bandage Set to…
Key Highlights Smart Bandage Breakthrough: A Strategic AI-Driven Platform from CaltechIn a landmark step toward intelligent wound management,…
Can Bayer’s Partnership with Altis Labs’ AI Boost…
Altis’ IPRO-Δ AI model outperforms RECIST in predicting survival, signaling a major shift in oncology trial endpoint Altis-Bayer…
Is IBM and Inclusive Brains’ AI-Quantum Fusion the…
Key Highlights Advancing Accessibility Through Multimodal AI and Brain-Machine InterfacesThe collaboration aims to improve the classification accuracy of…
AI at the FDA: Will ‘Elsa’ Redefine How…
Key highlights Regulatory AI Disruption: Why the FDA’s ‘Elsa’ Tool Is a Gamechanger for Biopharma The U.S. Food…
AI in Pharmacovigilance: Why Are Top Global Biopharma…
Key Highlights Industry Confidence Grows as NavaX Gains MomentumArisGlobal, a leader in life sciences technology, has announced the…
Can the FDA’s Elsa AI Transform Medical Device…
Key Takeaways Transforming the FDA’s Mission With Secure Generative AIIn a landmark step toward modernizing regulatory science, the…
Will Sanofi’s $9.5B Acquisition of Blueprint Redefine the…
Key Takeaways for Biopharma Executives Strategic Expansion: Sanofi Bets Big on Rare Immunology and US Biotech InnovationIn a…
Trending Posts
Latest Stories
Could Roche’s New Vabysmo Data Redefine Long-Term Care in “wet” age-related macular degeneration (nAMD)?
Key Highlights Durability Demonstrated in AVONELLE-XRoche presented four-year data from AVONELLE-X at the Euretina 2025…
Is Abbott’s Dissolving Stent Set to Transform Peripheral Artery Disease Treatment in Europe?
Key Highlights A Breakthrough in PAD TreatmentAbbott has received CE Mark approval in Europe for…
Could the Medtronic–Abbott Partnership Shift the Future of Diabetes Technology as FDA Clears MiniMed™ 780G for Broader Use?
Key Highlights Expanding Integration Through Abbott PartnershipThe U.S. FDA has cleared Medtronic’s SmartGuard™ algorithm as…
Could Medtronic’s Hugo™ Robotic System Redefine Hernia Surgery for 1.5M Patients in the U.S.?
Key Highlights A Landmark Clinical Study for Robotic Hernia SurgeryMedtronic’s Enable Hernia Repair trial is…
Gallery
